Ulla Mandel spends much of her time researching Molecular biology, MUC1, Glycosylation, Biochemistry and Antibody. Her studies deal with areas such as Polypeptide N-acetylgalactosaminyltransferase, Tandem repeat and Coding region as well as Molecular biology. Her work deals with themes such as Secretion and O-linked glycosylation, which intersect with Glycosylation.
Her Proteomics, Gene family and Gene study in the realm of Biochemistry connects with subjects such as Zinc finger nuclease. Her work on Epitope and Monoclonal antibody as part of general Antibody study is frequently linked to Antrum and Body region, therefore connecting diverse disciplines of science. Her studies examine the connections between Cancer and genetics, as well as such issues in Immunology, with regards to Cancer research.
Ulla Mandel mostly deals with Molecular biology, Glycosylation, Antigen, Monoclonal antibody and Mucin. Her work in Molecular biology addresses subjects such as Cell culture, which are connected to disciplines such as Cancer cell. She combines subjects such as MUC1, O-linked glycosylation and Glycoprotein, Glycan with her study of Glycosylation.
Her Antigen research integrates issues from Immunohistochemistry, Myoepithelial cell, Epithelium and Cell. As part of one scientific family, Ulla Mandel deals mainly with the area of Monoclonal antibody, narrowing it down to issues related to the Epitope, and often Autoantibody. Her Mucin research includes elements of Salivary gland, Colorectal cancer and Mucin 2.
Her scientific interests lie mostly in Glycosylation, Cancer research, Mucin, MUC1 and Cancer. Her Glycosylation research is multidisciplinary, incorporating elements of Molecular biology, Glycoproteomics, Glycan, Gene and Cell biology. Her Molecular biology course of study focuses on Epitope and Biochemistry and Immunochemistry.
Ulla Mandel has researched Cancer research in several fields, including Pancreatic cancer, Cancer cell, Antigen, Metastasis and Chimeric antigen receptor. Her biological study spans a wide range of topics, including Colorectal cancer, CA19-9, Monoclonal antibody and Adenoma. Her MUC1 study incorporates themes from Phenotype, Ovarian cancer and Serous fluid.
Her primary areas of investigation include Glycosylation, MUC1, Antigen, Cancer research and Colorectal cancer. Her studies in Glycosylation integrate themes in fields like Molecular biology, Glycoconjugate, Galectin and Glycan. Her Molecular biology research is multidisciplinary, relying on both Biochemistry, Immunoassay, Epitope, Monoclonal antibody and Tandem repeat.
Her Antigen research incorporates elements of Chimeric antigen receptor and Immunotherapy. Ulla Mandel has included themes like Cancer and Immunology in her Cancer research study. The Colorectal cancer study combines topics in areas such as Polypeptide N-acetylgalactosaminyltransferase, Cell culture and CA19-9.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology
Catharina Steentoft;Sergey Vakhrushev;Hiren Jitendra Joshi;Hiren Jitendra Joshi;Yun Kong.
The EMBO Journal (2013)
Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family
Eric P Bennett;Ulla Mandel;Henrik Clausen;Thomas A Gerken.
Glycobiology (2012)
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Avery D. Posey;Robert D. Schwab;Alina C. Boesteanu;Catharina Steentoft.
Immunity (2016)
Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis SECRETION OF FIBROBLAST GROWTH FACTOR 23 REQUIRES O-GLYCOSYLATION
Kentaro Kato;Charlotte Jeanneau;Mads Agervig Tarp;Anna Benet-Pagès.
Journal of Biological Chemistry (2006)
Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines
Catharina Steentoft;Sergey Y Vakhrushev;Malene B Vester-Christensen;Katrine T-B G Schjoldager.
Nature Methods (2011)
Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
Eric Paul Bennett;Helle Hassan;Ulla Mandel;Ekatarina Mirgorodskaya.
Journal of Biological Chemistry (1998)
Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Mads A. Tarp;Anne Louise Sørensen;Ulla Mandel;Hans Paulsen.
Glycobiology (2007)
Cloning and Characterization of a Close Homologue of Human UDP-N-acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase-T3, Designated GalNAc-T6 EVIDENCE FOR GENETIC BUT NOT FUNCTIONAL REDUNDANCY
Eric Paul Bennett;Helle Hassan;Ulla Mandel;Michael A. Hollingsworth.
Journal of Biological Chemistry (1999)
Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
Anne Louise Sørensen;Celso A. Reis;Celso A. Reis;Mads A. Tarp;Ulla Mandel.
Glycobiology (2006)
Cloning and Expression of a Proteoglycan UDP-Galactose:β-Xylose β1,4-Galactosyltransferase I A SEVENTH MEMBER OF THE HUMAN β4-GALACTOSYLTRANSFERASE GENE FAMILY
Raquel Almeida;Raquel Almeida;Steven B. Levery;Ulla Mandel;Hans Kresse.
Journal of Biological Chemistry (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Copenhagen
Novo Nordisk (Denmark)
University of Porto
King's College London
King's College London
University of Copenhagen
University of Nebraska Medical Center
University of Copenhagen
Juntendo University
University of Chicago
University of California, Santa Cruz
Iowa State University
Chung Yuan Christian University
University of Dhaka
University of Alberta
Boston College
Freie Universität Berlin
University of Massachusetts Medical School
Robert Koch Institute
University of Hawaii at Manoa
University of British Columbia
University of Birmingham
Newcastle University
Stanford University
University of Arkansas for Medical Sciences
University of Alabama at Birmingham